Livestrong.com on MSN2 天
Phenylephrine for Colds: Why It Doesn’t Work and What You Should Use Instead
Discover why oral phenylephrine in cold medicine is ineffective for relieving congestion. Learn which alternative treatments ...
Hydreight Technologies Expands Telehealth Offerings with Launch of NAD+ Therapy on VSDHOne ...
NAD+ IonToPatch – Utilizing iontophoresis, a non-invasive transdermal drug delivery system that uses a voltage gradient to increase skin permeability, allowing for effective NAD+ absorption. The latex ...
Ketamine-derived nasal spray treating Phoenix patients with severe depression
PHOENIX (AZFamily) — A ketamine-derived nasal spray is now available for the millions of Americans living with severe ...
UUHC Health Feed15 天
How Does Nasal Rinsing Work and Is It Safe?
While most people can benefit from a nasal rinse, it won’t work if you have severe inflammation in your nose blocking the nasal passages. Smith suggests using a decongestant spray for no more than ...
Indiatimes15 天
FDA approves J&J’s nasal spray for severe depression as stand-alone treatment
Johnson & Johnson's Spravato nasal spray has been FDA-approved as a stand ... meaning it can’t be purchased at a pharmacy and is only administered in certified health-care settings under strict ...
Daily15 天
FDA Approves Esketamine Nasal Spray for Treatment-Resistant Depression
The FDA has approved esketamine (Spravato) nasal spray as a monotherapy for adults with treatment-resistant depression. This approval applies to individuals who have had an inadequate response to at ...
Adelaide Now16 天
LTR Pharma inks national pharmacy distribution deal for its ED therapy
Special Report: LTR Pharma has inked a deal with leading pharmaceutical wholesaler in Australia Symbion Pty Ltd, to establish national distribution capabilities for Spontan, its novel nasal spray ...
Purdue Exponent16 天
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major ...
People warned to 'act now' as doctor says 'it's not too late'
The number of people in hospital with winter ailments is rising as doctor says it is 'posing challenges' on the wards ...
The Victoria Advocate17 天
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had ...
The Australian17 天
LTR Pharma inks national pharmacy distribution deal for its ED therapy
Special Report: LTR Pharma has inked a deal with leading pharmaceutical wholesaler in Australia Symbion Pty Ltd, to establish national distribution capabilities for Spontan, its novel nasal spray ...
FDA approves Johnson & Johnson’s nasal spray for depression as stand-alone treatment
Spravato is now the first-ever stand-alone therapy for treatment-resistant depression, and is on its way to becoming a blockbuster product.